JPWO2021151012A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021151012A5
JPWO2021151012A5 JP2022544353A JP2022544353A JPWO2021151012A5 JP WO2021151012 A5 JPWO2021151012 A5 JP WO2021151012A5 JP 2022544353 A JP2022544353 A JP 2022544353A JP 2022544353 A JP2022544353 A JP 2022544353A JP WO2021151012 A5 JPWO2021151012 A5 JP WO2021151012A5
Authority
JP
Japan
Prior art keywords
fusion protein
nucleic acid
recombinant virus
cell
acid construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022544353A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023511908A (ja
JP2023511908A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/014780 external-priority patent/WO2021151012A1/en
Publication of JP2023511908A publication Critical patent/JP2023511908A/ja
Publication of JPWO2021151012A5 publication Critical patent/JPWO2021151012A5/ja
Publication of JP2023511908A5 publication Critical patent/JP2023511908A5/ja
Pending legal-status Critical Current

Links

JP2022544353A 2020-01-22 2021-01-22 タウ発現抑制のためのジンクフィンガータンパク質転写因子 Pending JP2023511908A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062964501P 2020-01-22 2020-01-22
US62/964,501 2020-01-22
PCT/US2021/014780 WO2021151012A1 (en) 2020-01-22 2021-01-22 Zinc finger protein transcription factors for repressing tau expression

Publications (3)

Publication Number Publication Date
JP2023511908A JP2023511908A (ja) 2023-03-23
JPWO2021151012A5 true JPWO2021151012A5 (https=) 2024-02-09
JP2023511908A5 JP2023511908A5 (https=) 2024-02-09

Family

ID=74661487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544353A Pending JP2023511908A (ja) 2020-01-22 2021-01-22 タウ発現抑制のためのジンクフィンガータンパク質転写因子

Country Status (14)

Country Link
US (1) US20230242602A1 (https=)
EP (1) EP4093754A1 (https=)
JP (1) JP2023511908A (https=)
KR (1) KR20220131273A (https=)
CN (1) CN115210251A (https=)
AR (1) AR121118A1 (https=)
AU (1) AU2021209699A1 (https=)
BR (1) BR112022014160A2 (https=)
CA (1) CA3168805A1 (https=)
IL (1) IL294535A (https=)
MX (1) MX2022008953A (https=)
TW (1) TW202134288A (https=)
UY (1) UY39036A (https=)
WO (1) WO2021151012A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110214184B (zh) 2016-12-01 2024-07-02 桑格摩生物治疗股份有限公司 τ蛋白调节剂以及用于其递送的方法和组合物
KR20210070344A (ko) 2018-10-02 2021-06-14 상가모 테라퓨틱스, 인코포레이티드 타우 단백질의 조정을 위한 방법 및 조성물
KR20220071248A (ko) * 2019-10-02 2022-05-31 상가모 테라퓨틱스, 인코포레이티드 알파-시누클레인 발현을 억제시키기 위한 아연 핑거 단백질 전사 인자
WO2025193848A1 (en) * 2024-03-13 2025-09-18 Sangamo Therapeutics, Inc. Delivery of tau repressors using the blood-brain barrier penetrant capsid

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69534629D1 (de) 1994-01-18 2005-12-29 Scripps Research Inst Derivate von zinkfingerproteinen und methoden
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
ATE524545T1 (de) 1994-08-20 2011-09-15 Gendaq Ltd Verbesserungen bei oder im zusammenhang mit bindeproteinen zur erkennung von dna
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
WO2001053480A1 (en) 2000-01-24 2001-07-26 Sangamo Biosciences, Inc. Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
US20030044787A1 (en) 2000-05-16 2003-03-06 Joung J. Keith Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
US9394531B2 (en) 2008-05-28 2016-07-19 Sangamo Biosciences, Inc. Compositions for linking DNA-binding domains and cleavage domains
PT2566972T (pt) 2010-05-03 2020-03-02 Sangamo Biosciences Inc Composições para a ligação de módulos de dedo de zinco
AU2014312295C1 (en) 2013-08-28 2020-08-13 Sangamo Therapeutics, Inc. Compositions for linking DNA-binding domains and cleavage domains
CN106459894B (zh) 2014-03-18 2020-02-18 桑格摩生物科学股份有限公司 用于调控锌指蛋白表达的方法和组合物
WO2017011556A1 (en) * 2015-07-13 2017-01-19 The General Hospital Corporation Rare phosphorylated high molecular weight (hmw) tau species that are involved in neuronal uptake and propagation and applications thereof
EP3411056A4 (en) 2016-02-02 2019-10-02 Sangamo Therapeutics, Inc. COMPOUNDS FOR NETWORKING DNA BINDING DOMAINS AND SPLITTING DOMAINS
SG10201913948PA (en) 2016-08-24 2020-03-30 Sangamo Therapeutics Inc Engineered target specific nucleases
CN110214184B (zh) * 2016-12-01 2024-07-02 桑格摩生物治疗股份有限公司 τ蛋白调节剂以及用于其递送的方法和组合物
CA3115158A1 (en) 2018-10-02 2020-04-09 Sangamo Therapeutics, Inc. Engineered genetic modulators
KR20210070344A (ko) 2018-10-02 2021-06-14 상가모 테라퓨틱스, 인코포레이티드 타우 단백질의 조정을 위한 방법 및 조성물

Similar Documents

Publication Publication Date Title
JP7623423B2 (ja) 選択的スプライシングのアプタマー媒介性調節による遺伝子発現の調節
US9890394B2 (en) Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
WO2009052737A1 (en) Medicament for preventing and controlling alzheimer's disease
JP2015508760A5 (https=)
US12583902B2 (en) DNA-binding domain transactivators and uses thereof
US20190071486A1 (en) Method and composition for treating neuronal hyper-excitability
US20230242602A1 (en) Zinc finger protein transcription factors for repressing tau expression
CN114144425B (zh) 用于阿尔茨海默症的基因治疗
CN109206503A (zh) 一种蛋白用于制备防治阿尔茨海默病药物的用途
EP4161953A1 (en) Compositions and methods for the treatment of synucleinopathies
JPWO2021151012A5 (https=)
JP7680072B2 (ja) リプログラミング用機能性断片、組み合わせ、およびその用途
CN116218849A (zh) 针对utrophin激活治疗杜氏肌营养不良的sgRNA和应用
TWI888417B (zh) 用於抑制α-突觸核蛋白(SYNUCLEIN)表現之鋅指蛋白轉錄因子
JPWO2020245169A5 (https=)
JPWO2021067871A5 (https=)
JP2023545972A (ja) アルファ-シヌクレイン発現を抑制するための新規ジンクフィンガータンパク質転写因子
JPWO2020219726A5 (https=)
RU2021133872A (ru) Модуляторы экспрессии гена открытой рамки считывания 72 хромосомы 9 и их применения
CN121221803A (zh) 胰岛素基因疗法
IL321782A (en) Retro-aav and use in treating neurodegenerative diseases
WO2024138812A1 (zh) 在哺乳动物肌肉中特异性启动基因的启动子序列及其应用
WO2025076201A1 (en) Human-targeted zinc finger protein to treat angelman syndrome
KR20250097002A (ko) Oct4, Sox2, Klf4 단백질을 포함하는 엔지니어링된 바이러스-유사 입자를 유효성분으로 포함하는 노화의 예방 또는 치료용 약제학적 조성물
BR102020023425A2 (pt) Vetor biológico para tratamento de doenças neurodegenerativas com base em terapia gênica